{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:12:15Z","timestamp":1791141135888,"version":"4.1.0"},"reference-count":78,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4,15]]},"DOI":"10.1086\/500662","type":"journal-article","created":{"date-parts":[[2006,3,20]],"date-time":"2006-03-20T15:33:22Z","timestamp":1142868802000},"page":"S153-S163","source":"Crossref","is-referenced-by-count":133,"title":["Overview of the Epidemiological Profileand Laboratory Detection of Extended-Spectrum \u03b2-Lactamases"],"prefix":"10.1093","volume":"42","author":[{"given":"Michael A.","family":"Pfaller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Segreti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,4,15]]},"reference":[{"key":"key\n\t\t\t\t20171014015735_ref1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","article-title":"Extended-spectrum \u03b2-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat","volume":"14","author":"Bradford","year":"2001","journal-title":"Clin Microb Rev"},{"key":"key\n\t\t\t\t20171014015735_ref2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/AAC.39.6.1211","article-title":"A functional classification scheme for \u03b2-lactamases and its correlation with molecular structure","volume":"39","author":"Bush","year":"1995","journal-title":"Anti-microb Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref3","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/AAC.34.5.858","article-title":"Activities of \u03b2-lactam antibiotics against Escherichia coli strains producing extended-spectrum \u03b2-lactamases","volume":"34","author":"Jacoby","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1128\/AAC.39.2.458","article-title":"New extended-spectrum TEM-type \u03b2-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak","volume":"39","author":"Morosini","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1128\/AAC.43.5.1281","article-title":"An SHV-derived extended-spectrum \u03b2-lactamase in Pseudomonas aeruginosa","volume":"43","author":"Naas","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jac\/44.4.489","article-title":"Concurrent outbreaks of extended-spectrum \u03b2-lactamase\u2014producing organisms of the family Enterobacteriaceae in a Warsaw hospital","volume":"44","author":"Palucha","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jac\/20.3.323","article-title":"Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel \u03b2-lactamase","volume":"20","author":"Sirot","year":"1987","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/clinids\/10.4.879","article-title":"Plasmid-mediated resistance to third-generation cephalosporins caused by point mutations in TEM-type penicillinase genes","volume":"10","author":"Sougakoff","year":"1988","journal-title":"Rev Infect Dis"},{"key":"key\n\t\t\t\t20171014015735_ref9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0014-5793(88)80734-8","article-title":"Single amino acid substitution between SHV-1 \u03b2-lactamase and cefotaxime-hydrolyzing SHV-2 enzyme","volume":"231","author":"Barthelemy","year":"1988","journal-title":"FEBS Lett"},{"key":"key\n\t\t\t\t20171014015735_ref10","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1016\/S0021-9258(18)53748-0","article-title":"Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type \u03b2-lactamases probed by site-directed mutagenesis and three-dimensional modeling","volume":"268","author":"Huletsky","year":"1993","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20171014015735_ref11","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1128\/AAC.47.11.3554-3560.2003","article-title":"Extended-spectrum \u03b2-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type \u03b2-lactamases","volume":"47","author":"Paterson","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.46.1.1-11.2002","article-title":"Plasmid-determined AmpC-type \u03b2-lactamases","volume":"46","author":"Philippon","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0924-8579(99)00165-X","article-title":"CTX-M-type \u03b2-lactamases: an emerging group of extended-spectrum enzymes","volume":"14","author":"Tzouvelekis","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171014015735_ref14","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1128\/AAC.46.12.4038-4040.2002","article-title":"Chromosome-encoded Ambler class A \u03b2-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum \u03b2-lactamases","volume":"46","author":"Poirel","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref15","first-page":"289","article-title":"Two novel plasmid-mediated cefotaxime-hydrolyzing \u03b2-lactamases (CTX-M-5 and CTX-M-6) from Salmonella typhimurium","volume":"165","author":"Gazouli","year":"1998","journal-title":"FEMS Microbiol Lett"},{"key":"key\n\t\t\t\t20171014015735_ref16","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1128\/AAC.44.7.1970-1973.2000","article-title":"Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing \u03b2-lactamase (CTX-M-9) from Escherichia coli in Spain","volume":"44","author":"Sabate","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref17","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1128\/AAC.37.8.1637","article-title":"OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) \u03b2-lactamase from Pseudomonas aeruginosa","volume":"37","author":"Hall","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref18","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1128\/AAC.39.8.1881","article-title":"OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) \u03b2-lactamase from Pseudomonas aeruginosa","volume":"39","author":"Danel","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref19","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1128\/AAC.41.10.2188","article-title":"OXA-18, a class D clavulanic acid-inhibited extended-spectrum \u03b2-lactamase from Pseudomonas aeruginosa","volume":"41","author":"Philippon","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1046\/j.1198-743x.2001.00330.x","article-title":"Evolution and epidemiology of extended-spectrum \u03b2-lactamases (ESBLs) and ESBL-producing microorganisms","volume":"7","author":"Gniadkowski","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20171014015735_ref21","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1128\/AAC.34.11.2193","article-title":"Outbreak of ceftazidime resistance caused by extended-spectrum \u03b2-lactamases at a Massachusetts chronic-care facility","volume":"34","author":"Rice","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-119-5-199309010-00001","article-title":"Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins","volume":"119","author":"Meyer","year":"1993","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171014015735_ref23","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.280.14.1233","article-title":"Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella","volume":"280","author":"Rahal","year":"1998","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171014015735_ref24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/mdr.2000.6.297","article-title":"Detection of multiresistant ceftazidime-susceptible Klebsiella pneumoniae isolates lacking TEM-26 after class restriction of cephalosporins","volume":"6","author":"Urban","year":"2000","journal-title":"Microb Drug Resist"},{"key":"key\n\t\t\t\t20171014015735_ref25","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1128\/AAC.44.8.2182-2184.2000","article-title":"Selection of naturally occurring extended-spectrum TEM \u03b2-lactamase variants by fluctuating \u03b2-lactam pressure","volume":"44","author":"Blazquez","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0924-8579(02)00249-2","article-title":"Sustained activity and spectrum of selected extended-spectrum \u03b2-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: report from the SENTRY antimicrobial surveillance program (USA, 1997\u20132000)","volume":"21","author":"Jones","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171014015735_ref27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0732-8893(02)00470-4","article-title":"Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997\u20132000)","volume":"44","author":"Gales","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171014015735_ref28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0732-8893(01)00353-4","article-title":"Prevalence of extended spectrum \u03b2-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998\u201399)","volume":"42","author":"Bell","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl 2","key":"key\n\t\t\t\t20171014015735_ref29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1086\/320182","article-title":"Variations in the prevalence of strains expressing an extended-spectrum \u03b2-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region","volume":"32","author":"Winokur","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014015735_ref30","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/319757","article-title":"Extended-spectrum \u03b2-lactamase\u2014producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes","volume":"32","author":"Lautenbach","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014015735_ref31","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1007\/s00134-002-1521-1","article-title":"Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome","volume":"28","author":"Du","year":"2002","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t20171014015735_ref32","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1086\/342577","article-title":"Molecular epidemiology of a citywide outbreak of extended-spectrum \u03b2-lactamase\u2014producing Klebsiella pneumoniae infection","volume":"35","author":"Quale","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014015735_ref33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1532-5415.2001.4930270.x","article-title":"Colonization of skilled-care facility residents with antimicrobial-resistant pathogens","volume":"49","author":"Trick","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"key\n\t\t\t\t20171014015735_ref34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/jhin.2002.1331","article-title":"Risk factors in the acquisition of extended-spectrum \u03b2-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan","volume":"53","author":"Lin","year":"2003","journal-title":"J Hosp Infect"},{"key":"key\n\t\t\t\t20171014015735_ref35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/jhin.2000.0862","article-title":"An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum \u03b2-lactamase","volume":"47","author":"Pena","year":"2001","journal-title":"J Hosp Infect"},{"key":"key\n\t\t\t\t20171014015735_ref36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/jama.281.6.517","article-title":"Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes","volume":"281","author":"Wiener","year":"1999","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171014015735_ref37","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/infdis\/174.3.529","article-title":"Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation","volume":"174","author":"Schiappa","year":"1996","journal-title":"J Infect Dis"},{"issue":"Suppl 4","key":"key\n\t\t\t\t20171014015735_ref38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1086\/500663","article-title":"Extended-spectrum \u03b2-lactamases and clinical outcomes: current data","volume":"42","author":"Ramphal","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014015735_ref39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/srin.2002.34693","article-title":"Klebsiella and Enterobacter: antibiotic resistance and treatment implications","volume":"17","author":"Bouza","year":"2002","journal-title":"Semin Respir Infect"},{"key":"key\n\t\t\t\t20171014015735_ref40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0732-8893(03)00041-5","article-title":"Evaluation of MicroScan ESBL confirmation panel for Enterobacteriaceae-producing, extended-spectrum \u03b2-lactamases isolated in Japan","volume":"46","author":"Komatsu","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171014015735_ref41","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1002\/j.1460-2075.1986.tb04704.x","article-title":"Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli","volume":"5","author":"Honore","year":"1986","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t20171014015735_ref42","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1128\/AAC.31.2.295","article-title":"Molecular genetic analysis of cephalosporinase production and its role in \u03b2-lactam resistance in clinical isolates of Enterobacter cloacae","volume":"31","author":"Nicolas","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref43","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1128\/AAC.45.8.2331-2339.2001","article-title":"Mutation in Serratia marcescens AmpC \u03b2-lactamase producing high-level resistance to ceftazidime and cefpirome","volume":"45","author":"Raimondi","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref44","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1073\/pnas.78.8.4897","article-title":"ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type","volume":"78","author":"Jaurin","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20171014015735_ref45","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1042\/bj2720627","article-title":"Cloning, sequencing and analysis of the structural gene and regulatory region of the Pseudomonas aeruginosa chromosomal ampC beta-lactamase","volume":"272","author":"Lodge","year":"1990","journal-title":"Biochem J"},{"key":"key\n\t\t\t\t20171014015735_ref46","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1432-1033.1986.tb09601.x","article-title":"Sequence of the Citrobacter freundii OS60 chromosomal ampC beta-lactamase gene","volume":"156","author":"Lindberg","year":"1986","journal-title":"Eur J Biochem"},{"key":"key\n\t\t\t\t20171014015735_ref47","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1128\/AAC.43.4.957","article-title":"Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli","volume":"43","author":"Nelson","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref48","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/AAC.40.8.1953","article-title":"Sequencing and analysis of four new Enterobacter ampD alleles","volume":"40","author":"Ehrhardt","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref49","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0924-8579(02)00009-2","article-title":"Antimicrobial susceptibility of inducible AmpC \u03b2-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997\u20132000","volume":"19","author":"Pfaller","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20171014015735_ref50","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1128\/AAC.34.11.2200","article-title":"Novel plasmid-mediated \u03b2-lactamase (MIR-1) conferring resistance to oxyimino- and \u03b1-methoxy \u03b2-lactams in clinical isolates of Klebsiella pneumoniae","volume":"34","author":"Papanicolaou","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref51","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1128\/AAC.42.9.2352","article-title":"Salmonella enteritidis: AmpC plasmid-mediated inducible \u03b2-lactamase (DHA-1) with an ampR gene from Morganella morganii","volume":"42","author":"Barnaud","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref52","first-page":"35","article-title":"Outbreak of Klebsiella pneumoniae producing transferable AmpC-type \u03b2-lactamase (ACC-1) originating from Hafnia alvei","volume":"187","author":"Nadjar","year":"2000","journal-title":"FEMS Microbiol Lett"},{"key":"key\n\t\t\t\t20171014015735_ref53","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/jac\/40.6.823","article-title":"Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type \u03b2-lactamase exposed during an outbreak of SHV-5 extended-spectrum \u03b2-lactamase in a Leeds hospital","volume":"40","author":"M'Zali","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref54","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1128\/AAC.43.5.1206","article-title":"Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 \u03b2-lactamase production and loss of an outer membrane protein","volume":"43","author":"Stapleton","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref55","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1128\/JCM.38.5.1791-1796.2000","article-title":"Occurrence and detection of AmpC \u03b2-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center","volume":"38","author":"Coudron","year":"2000","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014015735_ref56","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1128\/AAC.45.4.1278-1280.2001","article-title":"New TEM variant (TEM-92) produced by Proteus mirabilis and Providencia stuartii isolates","volume":"45","author":"de Champs","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0732-8893(98)00117-5","article-title":"Characterization of the inoculum effect with Haemophilus influenzae and \u03b2-lactams","volume":"33","author":"Balko","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171014015735_ref58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jac\/2.2.115","article-title":"The \u03b2-lactamases of gram-negative bacteria and their role in resistance to \u03b2-lactam antibiotics","volume":"2","author":"Sykes","year":"1976","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref59","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/BF01962350","article-title":"In vivo significance of the inoculum effect of antibiotics on Escherichia coli","volume":"7","author":"Soriano","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171014015735_ref60","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/JCM.42.1.269-275.2004","article-title":"Effects of inoculum and \u03b2-lactamase activity in AmpC- and extended-spectrum \u03b2-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology","volume":"42","author":"Queenan","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014015735_ref61","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.diagmicrobio.2003.11.007","article-title":"In vitro killing of parenteral \u03b2-lactams against standard and high inocula of extended-spectrum \u03b2-lactamase and non-ESBL producing Klebsiella pneumoniae","volume":"49","author":"Burgess","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171014015735_ref62","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1128\/AAC.48.6.1941-1947.2004","article-title":"Determination of the in vivo pharmacodynamic profile of cefepime against extended-spectrum-\u03b2-lactamase\u2014producing Escherichia coli at various inocula","volume":"48","author":"Maglio","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref63","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.diagmicrobio.2004.07.006","article-title":"The inoculum effect: factor or artifact?","volume":"50","author":"Craig","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171014015735_ref64","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1128\/JCM.36.9.2575-2579.1998","article-title":"Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of \u03b2-lactamase production among Escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?","volume":"36","author":"Moland","year":"1998","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014015735_ref65","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1086\/313788","article-title":"Antimicrobial susceptibility testing: special needs for fastidious organisms and difficult-to-detect resistance mechanisms","volume":"30","author":"Jorgensen","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014015735_ref66","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3201\/eid0702.010238","article-title":"Controversies about extended-spectrum and AmpC beta-lactamases","volume":"7","author":"Thomson","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20171014015735_ref67","first-page":"1","volume-title":"Performance standards for antimicrobial disk susceptibility tests: 15th informational supplement, M100-S15","author":"NCCLS","year":"2005"},{"key":"key\n\t\t\t\t20171014015735_ref68","first-page":"149","article-title":"Utilization of extended-spectrum beta-lactamase (ESBL) detection systems in microbiology laboratories: survey of Connecticut hospitals from 1998\u20132002","volume":"67","author":"Dandekar","year":"2003","journal-title":"Conn Med"},{"key":"key\n\t\t\t\t20171014015735_ref69","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/jac\/45.2.183","article-title":"Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997\u20131998","volume":"45","author":"Babini","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref70","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1128\/JCM.37.12.4065-4070.1999","article-title":"Detection and reporting of organisms producing extended-spectrum \u03b2-lactamases: survey of laboratories in Connecticut","volume":"37","author":"Tenover","year":"1999","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014015735_ref71","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/bmj.327.7425.1209","article-title":"Recent developments in \u03b2 lactamases and extended spectrum \u03b2 lactamases","volume":"327","author":"Samaha-Kfoury","year":"2003","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20171014015735_ref72","first-page":"56","article-title":"Commercial broth-and agar-based MIC systems for detection and confirmation of ESBL-producing gram-negative bacilli","volume-title":"VITEK, Microscan, Etest [monograph]","author":"Pfaller","year":"2003"},{"key":"key\n\t\t\t\t20171014015735_ref73","article-title":"A multicenter survey of the various antibiotics ability to detect ESBL-producing Klebsiella spp. and E. coli [abstract P-1348]: presentation at the 10th European Congress on Clinical Microbiology and Infectious Disease (Stockholm)","volume-title":"Clin Microbiol Infect","author":"Roe","year":"2000"},{"key":"key\n\t\t\t\t20171014015735_ref74","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/AAC.43.6.1393","article-title":"Use of microdilution panels with and without \u03b2-lactamase inhibitors as a phenotypic test for \u03b2-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens","volume":"43","author":"Thomson","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref75","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/JCM.38.2.570-574.2000","article-title":"Ability of the VITEK 2 advanced expert system to identify \u03b2-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa","volume":"38","author":"Sanders","year":"2000","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014015735_ref76","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jac\/49.2.289","article-title":"Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests","volume":"49","author":"Livermore","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014015735_ref77","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1128\/JCM.34.8.1880-1884.1996","article-title":"Detection of extended-spectrum \u03b2-lactamase (ESBL)-producing strains by the Etest ESBL screen","volume":"34","author":"Cormican","year":"1996","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014015735_ref78","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1128\/JCM.40.10.3703-3711.2002","article-title":"Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum \u03b2-lactamases in multiresistant Escherichia coli and Klebsiella spp","volume":"40","author":"Leverstein-van Hall","year":"2002","journal-title":"J Clin Microbiol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/42\/Supplement_4\/S153\/20907152\/42-Supplement_4-S153.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T01:37:25Z","timestamp":1627177045000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/42\/Supplement_4\/S153\/324449\/Overview-of-the-Epidemiological-Profileand"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,15]]},"references-count":78,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2006,4,15]]},"published-print":{"date-parts":[[2006,4,15]]}},"URL":"https:\/\/doi.org\/10.1086\/500662","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,4,15]]},"published":{"date-parts":[[2006,4,15]]}}}